Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-18

Clinical Trial Update: Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 study comparing the IOP-lowering efficacy of Azopt 1.0% versus Timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azopt (brinzolamide)
  • Timolol (timolol)

Snippet

Sponsor: Alcon Research | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED